Galmed Pharmaceuticals (GLMD) Operating Margin (2016 - 2018)

Galmed Pharmaceuticals' Operating Margin history runs 3 years deep, the most recent figure standing at 954.85% for Q1 2018.

• In Q1 2018, Operating Margin fell 26306.0% year-over-year to 954.85%; the TTM figure through Mar 2018 stood at 1276.41% (down 81788.0% YoY), while the FY2018 annual figure was 57.61%, up 119714.0% from the prior year.
• Operating Margin was 954.85% for Q1 2018 at Galmed Pharmaceuticals, down from 1217.91% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 1971.5% in Q3 2016 to a low of 954.85% in Q1 2018.
• Historically, Operating Margin has averaged 1381.42% across 3 years, with a median of 1217.91% in 2017.
• Biggest YoY gain for Operating Margin was 26306 bps in 2018; the steepest drop was 26306 bps in 2018.
• A 3-year view of Operating Margin shows it stood at 1971.5% in 2016, then plunged by 38 bps to 1217.91% in 2017, then slipped by 22 bps to 954.85% in 2018.
• The last three Operating Margin figures came in at 954.85% (Q1 2018), 1217.91% (Q1 2017), and 1971.5% (Q3 2016), per Business Quant data.